Press "Enter" to skip to content

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

The decision comes about two months after an FDA advisory panel failed to reach a consensus over whether the once-daily oral drug, sotagliflozin, should be approved as an add-on to insulin therapy.

Original source:

Also Read:   Suicide attempts rising among black teens